Form 4 for EW Edwards Lifesciences
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-17 · accession 0001225208-21-015136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-17 | 2021-12-17 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| D | 2021-12-17 | 2021-12-17 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $121.24 | -10.0K | 27.4K | -27% | -$1.21M |
| D | 2021-12-17 | 2021-12-17 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | -10.0K | 93.4K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-17 | M | A | 10,000 | $21.76 | 37,414.52 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-17 | S | D | 10,000 | $121.24 | 27,414.52 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2021-12-17 | M | D | 10,000 | $0.00 | 93,400 | D | $21.76 · 2016-05-14 to 2022-05-13 | 10,000 Common Stock |